Mozart Therapeutics is based in Seattle, WA. It has raised $80M in total funding. Latest round: Series A.
Mozart Therapeutics is based in Seattle, WA. Mozart Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Mozart Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Sofinnova Partners, Eli Lilly & Company, MRL Ventures Fund, Leaps by Bayer, Altitude Life Science Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Totals shown for Mozart Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026